Rome Madison, Founder of Genetics for Healthcare Podcast and President of Genomic Selling Solutions, shared a post on LinkedIn:
“Genetics for Healthcare Podcast #33
I’m incredibly grateful for our growing community here on LinkedIn and for everyone who has been watching and engaging with our content. Your dedication to understanding and advocating for precision medicine is truly inspiring, and it’s why we do what we do!
Today, I’m thrilled to announce a landmark episode that represents the first in a series of conversations we’ll be having with healthcare institutions that are not just talking about precision medicine, but are actually scaling programs targeting the point-of-care.
Ronan Kelly shares the bold plan for Texas Cancer Interception Institute to transform early cancer detection in Texas. Baylor Scott and White Health, one of the nation’s largest non-profit health systems, is leveraging cutting-edge diagnostics, at-home genetic screenings, AI, and digital platforms to make early cancer detection widely accessible.
Health systems WHO ARE NOT taking action to make genetic and genomic testing routine hinder our ability to reach the national goals to reduce cancer deaths by at least 50% by the year 2047.”
Ronan Kelly, Chief of Oncology at Baylor Scott and White Health, shared this post, adding:
“Thank you to Rome Madison and the Genetics for Healthcare podcast for discussing the Texas Cancer Interception Institute and how we plan to use new technologies and assays to detect cancer earlier than ever before.”
Proceed to watch the podcast attached to the post.